Organigram Global Inc. (TSX:OGI)
1.930
+0.020 (1.05%)
Apr 8, 2026, 11:30 AM EST
Organigram Global Revenue
Organigram Global had revenue of 63.54M CAD in the quarter ending December 31, 2025, with 48.70% growth. This brings the company's revenue in the last twelve months to 279.99M, up 68.55% year-over-year. In the fiscal year ending September 30, 2025, Organigram Global had annual revenue of 259.18M with 62.15% growth.
Revenue (ttm)
279.99M
Revenue Growth
+68.55%
P/S Ratio
0.93
Revenue / Employee
246.25K
Employees
1,137
Market Cap
260.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 259.18M | 99.34M | 62.15% |
| Sep 30, 2024 | 159.84M | -1.80M | -1.11% |
| Sep 30, 2023 | 161.64M | 15.83M | 10.86% |
| Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
| Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
| Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
| Aug 31, 2019 | 80.41M | 67.98M | 546.98% |
| Aug 31, 2018 | 12.43M | -377.00K | -2.94% |
| Aug 31, 2017 | 12.81M | 550.75K | 4.49% |
| Aug 31, 2016 | 12.26M | 11.27M | 1,142.07% |
| Aug 31, 2015 | 986.68K | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 899.24M |
| Ascend Wellness Holdings | 686.36M |
| Aurora Cannabis | 373.12M |
| TerrAscend | 357.26M |
| Auxly Cannabis Group | 151.48M |
| Cannara Biotech | 112.25M |
| HLS Therapeutics | 76.10M |
| Cipher Pharmaceuticals | 69.17M |
Organigram Global News
- 8 days ago - Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting - Business Wire
- 16 days ago - Organigram (OGI) Gains Support for Sanity Group Acquisition - GuruFocus
- 16 days ago - Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH - Business Wire
- 4 weeks ago - Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting - Business Wire
- 4 weeks ago - Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity - Business Wire
- 5 weeks ago - 3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio - MarijuanaStocks
- 6 weeks ago - Organigram (OGI) Expands Product Line in Australia with New Launch - GuruFocus
- 6 weeks ago - Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia - Business Wire